GLP-1 receptor agonists and the risk for cancer: A meta-analysis of randomized controlled trials.

Diabetes Obes Metab · 2025 · PMC12232360 · PMID 40437949

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

did not reach statistical significancep = 0.24not close (p > 0.1)

The difference between GLP‐1RA and the comparator did not reach statistical significance (MH‐OR 0.77, 95% CI [0.50, 1.18], p = 0.24, I 2 = 0%, Figure 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.